REDUCTIONS
III.F.3-4 Falck, J.R., Mioskowski, C. et al., TL, 35, 5437.
219
R
S0 2 Ph
ττ so 2 Ph
1; LiNp
2:H 2 0
R
S0 2 Ph
X
R*' H
0-97 %
III.F.3-5 Alcaide, B., Sierra, M.A. et al., JOC, 59,7934.
R2 SMe
R2
Rl-SMe N ici r 6H 2 0, NaBH 4
Rl ~
>—N s
aq THF, -20°C to rt
J~N v
OR
OR
18-90 %
III.G. Reductive Cleavages
III.G.l. Oxiranes
III.G.1-1 Guanti, G. et al., 7, 50, 2219.
OR2
OR3
B U3 SnH,AIBN
R
1
OH 99%
III.F.3-4 Falck, J.R., Mioskowski, C. et al., TL, 35, 5437.
219
R
S0 2 Ph
ττ so 2 Ph
1; LiNp
2:H 2 0
R
S0 2 Ph
X
R*' H
0-97 %
III.F.3-5 Alcaide, B., Sierra, M.A. et al., JOC, 59,7934.
R2 SMe
R2
Rl-SMe N ici r 6H 2 0, NaBH 4
Rl ~
>—N s
aq THF, -20°C to rt
J~N v
OR
OR
18-90 %
III.G. Reductive Cleavages
III.G.l. Oxiranes
III.G.1-1 Guanti, G. et al., 7, 50, 2219.
OR2
OR3
B U3 SnH,AIBN
R
1
OH 99%